Average Co-Inventor Count = 7.02
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (13 from 4,942 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
13 patents:
1. 12421240 - Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease
2. 12421252 - Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease
3. 12351575 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
4. 11713327 - Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
5. 11168086 - Methods of synthesizing pyrazine compounds
6. 10683299 - Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases
7. 10562905 - Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseases
8. 10428069 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
9. 10081627 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
10. 9890167 - Pyrazine compounds for the treatment of infectious diseases
11. 9758530 - 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
12. 9266904 - 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
13. 9233978 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection